1. Myocardial infarction: symptoms and treatments. Cell biochemistry and biophysics;Lu L,2015
2. Acheampong P, Ford GA. Pharmacokinetics of alteplase in the treatment of ischaemic stroke. Expert opinion on drug metabolism & toxicology. 2012 Feb 1;8(2):271 – 81.
3. Diagnosis and management of transient ischemic attack and acute ischemic stroke: a review;Mendelson SJ;Jama. 2021 Mar
4. Whiteley WN, Emberson J, Lees KR, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J. Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. The Lancet Neurology. 2016 Aug 1;15(9):925 – 33.
5. Collet JP, Thiele H. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation–Dual versus triple antithrombotic therapy. European heart journal. 2021 May 21;42(20):2020-1.